Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

MeSH terms

• Clinical Trials as Topic / standards*
• Consensus
• Drugs, Investigational / therapeutic use
• Healthy Lifestyle
• Humans
• Liver / pathology
• Liver Cirrhosis / etiology
• Liver Cirrhosis / pathology
• Liver Cirrhosis / therapy*
• Non-alcoholic Fatty Liver Disease / complications
• Non-alcoholic Fatty Liver Disease / pathology
• Non-alcoholic Fatty Liver Disease / therapy*
• Patient Selection*
• Practice Guidelines as Topic*
• Stakeholder Participation